Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith Borcoman

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Current Opinion in Oncology|July 2, 2019
Molecular screening programs in different countries: what we learned and perspectivesEdith Borcoman, Christophe Le Tourneau, Maud Kamal
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Patterns of Response and Progression to ImmunotherapyEdith Borcoman, Amara Nandikolla, Georgina Long, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 13, 2020
Pseudoprogression and Hyperprogression as New Forms of Response to ImmunotherapyMaxime Frelaut, Pauline du Rusquec, Alexandre de Moura, et al.
La Revue Du Praticien|March 19, 2021
[Imaging strategy for breast cancer screening]Edith Borcoman, Marie Attard, Julia Arfi-Rouche, et al.
Cancers|January 11, 2022
HDAC Inhibition to Prime Immune Checkpoint InhibitorsEdith Borcoman, Maud Kamal, Grégoire Marret, et al.
Bulletin Du Cancer|October 21, 2018
[Hot topics about early clinical trials at ASCO congress 2018: News pathways, new targets, new associations]Marie Auvray, Camille Baylot, Félix Blanc-Durand, et al.
Chinese Clinical Oncology|October 11, 2024
Phase I trials of single-agent new drugs in head and neck cancer: a scoping reviewDaria Maria Filippini, Gregoire Marret, Etienne Bastien, et al.
JNCI Cancer Spectrum|April 28, 2020
Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell CarcinomaPaul Gougis, Camille Moreau Bachelard, Maud Kamal, et al.
Journal of Critical Care|February 8, 2020
One-year survival in patients with solid tumours discharged alive from the intensive care unit after unplanned admission: A retrospective studyEdith Borcoman, Axelle Dupont, Eric Mariotte, et al.
The Breast Journal|April 14, 2025
Development of a Prognostic Score in Patients With Advanced Breast Cancer Treated for Meningeal CarcinomatosisGrégoire Narjoux, Juliette Mainguené, Marie-Noëlle Guilhaume, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Current Opinion in Oncology|July 2, 2019
Molecular screening programs in different countries: what we learned and perspectivesEdith Borcoman, Christophe Le Tourneau, Maud Kamal
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Patterns of Response and Progression to ImmunotherapyEdith Borcoman, Amara Nandikolla, Georgina Long, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 13, 2020
Pseudoprogression and Hyperprogression as New Forms of Response to ImmunotherapyMaxime Frelaut, Pauline du Rusquec, Alexandre de Moura, et al.
La Revue Du Praticien|March 19, 2021
[Imaging strategy for breast cancer screening]Edith Borcoman, Marie Attard, Julia Arfi-Rouche, et al.
Cancers|January 11, 2022
HDAC Inhibition to Prime Immune Checkpoint InhibitorsEdith Borcoman, Maud Kamal, Grégoire Marret, et al.
Bulletin Du Cancer|October 21, 2018
[Hot topics about early clinical trials at ASCO congress 2018: News pathways, new targets, new associations]Marie Auvray, Camille Baylot, Félix Blanc-Durand, et al.
Chinese Clinical Oncology|October 11, 2024
Phase I trials of single-agent new drugs in head and neck cancer: a scoping reviewDaria Maria Filippini, Gregoire Marret, Etienne Bastien, et al.
JNCI Cancer Spectrum|April 28, 2020
Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell CarcinomaPaul Gougis, Camille Moreau Bachelard, Maud Kamal, et al.
Journal of Critical Care|February 8, 2020
One-year survival in patients with solid tumours discharged alive from the intensive care unit after unplanned admission: A retrospective studyEdith Borcoman, Axelle Dupont, Eric Mariotte, et al.
The Breast Journal|April 14, 2025
Development of a Prognostic Score in Patients With Advanced Breast Cancer Treated for Meningeal CarcinomatosisGrégoire Narjoux, Juliette Mainguené, Marie-Noëlle Guilhaume, et al.
Pageof 6